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Abstract
Background: If the proportional assist ventilation (PAV) level is known, muscular effort can be estimated from
the difference between peak airway pressure and positive end-expiratory pressure (PEEP) (ΔP) during PAV.
We conjectured that deducing muscle pressure from ΔP may be an interesting method to set PAV, and tested this
hypothesis using the oesophageal pressure time product calculation.
Methods: Eleven mechanically ventilated patients with oesophageal pressure monitoring under PAV were enrolled.
Patients were randomly assigned to seven assist levels (20–80%, PAV20 means 20% PAV gain) for 15 min. Maximal
muscular pressure calculated from oesophageal pressure (Pmus, oes) and from ΔP (Pmus, aw) and inspiratory pressure
time product derived from oesophageal pressure (PTPoes) and from ΔP (PTPaw) were determined from the last minute
of each level. Pmus, oes and PTPoes with consideration of PEEPi were expressed as Pmus, oes, PEEPi and PTPoes, PEEPi,
respectively. Pressure time product was expressed as per minute (PTPoes, PTPoes, PEEPi, PTPaw) and per breath (PTPoes, br,
PTPoes, PEEPi, br, PTPaw, br).
Results: PAV significantly reduced the breathing effort of patients with increasing PAV gain (PTPoes 214.3 ± 80.0 at
PAV20 vs. 83.7 ± 49.3 cmH2O•s/min at PAV80, PTPoes, PEEPi 277.3 ± 96.4 at PAV20 vs. 121.4 ± 71.6 cmH2O•s/min at PAV80,
p < 0.0001). Pmus, aw overestimates Pmus, oes for low-gain PAV and underestimates Pmus, oes for moderate-gain to
high-gain PAV. An optimal Pmus, aw could be achieved in 91% of cases with PAV60. When the PAV gain was
adjusted to Pmus, aw of 5–10 cmH2O, there was a 93% probability of PTPoes <224 cmH2O•s/min and 88% probability
of PTPoes, PEEPi < 255 cmH2O•s/min.
Conclusion: Deducing maximal muscular pressure from ΔP during PAV has limited accuracy. The extrapolated
pressure time product from ΔP is usually less than the pressure time product calculated from oesophageal pressure
tracing. However, when the PAV gain was adjusted to Pmus, aw of 5–10 cmH2O, there was a 90% probability of PTPoes
and PTPoes, PEEPi within acceptable ranges. This information should be considered when applying ΔP to set PAV under
various gains.
Keywords: Pressure time product, Proportional assist ventilation, Airway pressure
* Correspondence: cwchen@mail.ncku.edu.tw
3Medical Intensive Care Unit, Department of Internal Medicine, National
Cheng Kung University Hospital, College of Medicine, National Cheng Kung
University, Tainan, Taiwan
5Medical Device Innovation Center, National Cheng Kung University, Tainan,
Taiwan
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Su et al. Critical Care  (2016) 20:382 
DOI 10.1186/s13054-016-1554-4
Background
Although mechanical ventilation is a crucial tool in de-
creasing the respiratory effort required by ventilated pa-
tients, diaphragmatic weakness can rapidly develop with
complete diaphragmatic inactivity and mechanical ventila-
tion [1]. This type of diaphragmatic powerlessness has
been termed ventilator-induced diaphragmatic dysfunction
(VIDD) [2]. Controlled mechanical ventilation is a major
factor in VIDD, which may be attenuated with assisted
ventilation [3, 4]. This suggests that maintaining appropri-
ate respiratory effort may be essential to preserving dia-
phragm function, and the ability to monitor respiratory
effort during mechanical ventilation should be an import-
ant clinical issue [5].
Pressure applied to the respiratory system is usually
assumed to dissipate against resistant and elastic ele-
ments. In a mechanically ventilated patient, the applied
pressure is shared between the patient and ventilator
[6]. This equation is difficult to solve under conven-
tional ventilation because it is challenging to obtain reli-
able values for respiratory system resistance and
elastance. However, in proportional assist ventilation
(PAV), obtaining reliable elastance is possible during
spontaneous breathing because the end of inspiration
can be determined [7–9].
PAV with load-adjustable gain factors (PAV+) is a
ventilatory mode that delivers assistance in proportion
to the instantaneous flow and volume by calculating
the instantaneous pressure needed to overcome the
elastic and resistive pressures; these are updated sev-
eral times per minute during PAV ventilation [10].
The proportion assistance is expressed as a percent-
age of the total pressure assisted (i.e. gain). By using
this algorithm, Carteaux et al. [11] proposed a look-
up table for estimating peak muscular pressure from
peak airway pressure (Paw, peak) and positive end-
expiratory pressure (PEEP) difference (ΔP), thus offer-
ing a way to keep the patient in a predefined comfort
zone by adjusting the PAV gain. However, this algo-
rithm has not yet been validated [12].
The oesophageal pressure time product (PTPoes) is a
standard reference to assess respiratory muscle pressure. In
patients with successful weaning, inspiratory PTPoes is
usually <224–255 cmH2O · s/min throughout the weaning
trial [13]. In addition to possible variability in respiratory
elastance and resistance measured during PAV+, respiratory
muscular PTP as estimated by Carteaux’s method requires
several assumptions that may limit its accuracy (e.g. a
triangular muscular pressure waveform and a defined
inspiratory time based on Paw, peak) [11]. Thus, the derived
muscular PTP may not be equal to the PTPoes. The present
study aimed to verify the applicability of Carteaux’s method
with measured Pmus, oes, Pmus, oes, PEEPi, PTPoes, and PTPoes,
PEEPi under different PAV gain settings.
Methods
From June 2014 to October 2014, all mechanically venti-
lated patients in our respiratory intensive care unit (10
beds) were screened daily for appropriateness for study in-
clusion. Patients had to be haemodynamically stable with-
out inotropic agents and had to be ventilated with an
inspiratory oxygen fraction <0.5 and PEEP ≤8 cmH2O.
They also had to agree to oesophageal balloon placement.
Exclusion criteria were pregnancy, acute coronary syn-
drome, aortic dissection as a cause of admission, and nasal
or oropharyngeal lesions that prohibited oesophageal bal-
loon placement. We used a single type of ventilator, the
Puritan-Bennett 840 with PAV+ mode (Tyco International,
Princeton, NJ, USA). The National Cheng Kung University
Hospital Ethics Committee (A-BR-102-090) approved this
study. The patient’s next of kin gave informed consent.
The oesophageal balloon was placed in the lower third
of the oesophagus and inflated with 0.5–1 mL of air.
Airflow was measured via a pneumotachograph (PN
155362, Hamilton Medical, Bonaduz, Switzerland),
while the airway and oesophageal pressures were indi-
vidually measured using two differential pressure trans-
ducers (P/N 113252, Model 1110A, Hans Rudolph,
Shawnee, KS, USA). The flow sensor was placed be-
tween the endotracheal tube and ventilator Y-piece.
Tidal volume was obtained by integration of the flow
signal. All signals were sampled and digitalized at
100 Hz, and data were stored in a data-acquisition sys-
tem (AcqKnowledgement, Biopac MP150, Goleta, CA,
USA). All patients were assessed in a 30° supine
position with endotracheal suction performed before
measurement if clinically required.
For individual patients, seven PAV gain levels (per-
centage of assistance), namely PAV20 (20% gain),
PAV30, PAV40, PAV50, PAV60, PAV70, and PAV80,
were randomly applied for 15 min at each level unless
the patients showed discomfort. Respiratory mechan-
ics measured by the ventilator during PAV were re-
corded throughout the course. Passive respiratory
mechanics were measured under constant flow at the
end of this protocol by increasing the back-up
mandatory ventilator rate until all the breathing
efforts were suppressed [13, 14].
Physiological measurement
Validation of oesophageal pressure measurement
Appropriate oesophageal balloon placement was verified
by the occlusion test [15]. The ratios of change in
oesophageal pressure to the change in airway opening
pressure (ΔPoes/ΔPaw) during three to five spontaneous
respiratory efforts against a closed airway were deter-
mined to ensure oesophageal pressure measurement
reliability.
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Respiratory mechanics during PAV and passive mechanical
ventilation
The respiratory mechanics (Epav and Rpav) during different
PAV levels were recorded as a display on the ventilator
screen. The last five Epav and five Rpav at each PAV level
were used for comparison. The respiratory system me-
chanics under constant flow and volume-cycled passive
mechanical ventilation were determined at the end of the
protocol using constant flow and a rapid airway occlusion
technique [16, 17].
Maximum inspiratory muscular pressure with Poes tracing
(Pmus, oes) and inspiratory oesophageal pressure time
product per breath (PTPoes, br)
Muscular pressure was calculated by taking into account
dynamic Ecw, which was obtained as the passive volume-
oesophageal pressure slope [13]. Pmus, oes was defined as
the maximum difference between the passive and active
Poes. The inspiratory PTPoes was calculated as the area be-
tween the Pcw and Poes tracing, starting from the onset of
inspiratory effort to the end of inspiratory flow. Pcw was
obtained by multiplying the tidal volume by dynamic Ecw.
The onset of inspiratory effort was determined by the
rapid descent point from Poes. We calculated PTPoes with
and without consideration of the intrinsic PEEP (PEEPi)
[13]. Because gastric pressure was not measured, exact
amounts of dynamic hyperinflation and expiratory muscle
activity were unknown. The PTPoes was thus presented in
two forms, the upper bound PTPoes, which attributes the
rapid descent of Poes before the onset of inspiratory flow
solely to inspiratory muscle activity, and the lower bound
PTPoes, which attributes the rapid descent of Poes solely to
cessation of expiratory effort [13, 14]. PTPoes, PEEPi and
PTPoes thus represent the upper and lower bounds of
PTP, respectively (Fig. 1).
Maximum inspiratory pressure from ΔP and PAV gain
(Pmus, aw) and inspiratory pressure time product from
airway per breath (PTPaw, br)
Pmus, aw during PAV was obtained by using the formula
adopted by Carteaux [11]:
Pmus; aw ¼ Paw; peak− PEEP
   100 − gainð Þ=gain:
PTPaw, br was calculated under the assumption of a
triangular inspiratory path with the end of inspiratory
effort at Paw, peak.
Statistical analysis
The results are given as mean ± SD, unless otherwise
specified. The Kruskal-Wallis test was used to compare
means from different groups. Dunn’s multiple comparison
test was performed over pairs of groups. Repeated mea-
sured analysis of variance (ANOVA) was used to compare
the means of Epav and Rpav measured by the ventilator
during various PAV gain levels. Correlatios between
PTPoes, br and Pmus, oes, PTPoes, PEEPi, br and Pmus, oes, PEEPi,
and PTPaw, br and Pmus, aw were analysed using the
two-tailed Spearman correlation test. Linear regression
between PTPoes, br and Pmus, oes, PTPoes, PEEP, br and Pmus,
oes, PEEPi, and PTPaw, br and Pmus, aw was analysed with a
forced regression line through the origin. Limits of agree-
ment between Pmus, aw and Pmus, oes were examined using
Bland-Altman analysis. All tests were two-sided, and a p

















































Fig. 1 Graphic illustration of flow, airway pressure (Paw), and oesophageal
pressure tracing (Poes) during proportional assist ventilation. Chest wall
recoil pressure (Pcw) was calculated from the product of tidal volume and
dynamic chest wall elastance. Upper bound oesophageal pressure time
product (PTPoes, PEEPi) was calculated as the integration of the difference
between Pcw, PEEPi and Poes. Lower bound oesophageal pressure time
product (PTPoes) was calculated as the integration of the difference
between Pcw and Poes. Pmus, oes and Pmus, oes, PEEPi represent the maximal
difference between passive and active Poes
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All analyses were performed using Prism version 5
(GraphPad Software, San Diego, CA, USA).
Results
The results of 18 consecutive patients who fulfilled the in-
clusion criteria were recorded. Two patients were excluded
from further analysis because of a low ΔPoes/ΔPaw ratio.
One patient was excluded because of a poor oesophageal
pressure signal, and four patients were excluded because of
an inadequate duration of Poes tracing secondary to the
intolerance of the patients to low-gain PAV. Ultimately, 11
patients with an adequate duration of PAV recording at all
stages of PAV support were analysed. The clinical demo-
graphics and respiratory mechanics of these patients are
shown in Table 1. The tidal volume, Paw, peak, Epav, and Rpav
under various PAV gain levels are shown in Fig. 2. Signifi-
cantly higher tidal volumes were found with high PAV
gains. As predicted, Ppeak increased with PAV gain. There
were no significant changes in Rpav, but Epav was signifi-
cantly higher with a high PAV gain (p < 0.0001).
PTPoes, PTPoes, PEEPi, peak muscular pressure and duration
of inspiration (Ti) with different PAV gains and their
correlation analysis
PTPoes and PTPoes, PEEPi during various PAV gain factors
are shown in Fig. 3. Progressive reductions in PTPoes
and PTPoes, PEEPi were noted with increasing PAV gain
levels. Significant differences were found among those
with low-gain and high-gain PAV (p < 0.0001). However,
no significant difference in PTPoes or PTPoes, PEEPi was
found between PAV20 vs. PAV30, PAV30 vs. PAV40,
PAV40 vs. PAV50, or PAV50 vs. PAV60. Pmus, aw tended
to underestimate Pmus, oes or Pmus, oes, PEEPi with all
levels of PAV gain except PAV20 (Fig. 4a). The minimal
difference between Pmus, aw and Pmus, oes was at the level
of PAV30 (Fig. 4a). The Ti, aw estimated from the onset
of inspiratory effort to Paw, peak was not different from
that estimated from flow tracing from PAV20 to PAV50.
However, the Ti, aw was significantly shortened compared
to the Ti estimated from flow tracing within PAV60 to
PAV80 (data not shown, p < 0.0001). Spearman correl-
ation analysis revealed significant correlation between
Pmus, aw and PTPaw, br (r
2 = 0.9341), Pmus, oes and PTPoes,
br(r
2 = 0.8751), and Pmus, oes, PEEPi and PTPoes, PEEPi, br
(r2 = 0.8862). Linear regression analysis disclosed the
best-fit slope between PTPaw, br and Pmus, aw to be 0.56,
between PTPoes, br and Pmus, oes to be 0.73, and between
PTPoes, PEEPi, br and Pmus, oes, PEEPi to be 0.83.
Bland-Altman analysis of Pmus between Pmus, aw and Pmus,
oes and selection of optimal Pmus
There was limited agreement between Pmus, aw and Pmus,
oes as determined by Bland-Altman analysis (Fig. 4b).
The bias was -1.2 cmH2O. The 95% confidence interval




















13/7.5/3.73 0.35/0 21.71 9.96 22.38 10.37 0.94
2 88/M Pneumonia,
COPD
7/7.0/4.92 0.40/8 15.28 5.57 27.11 21.55 1.03
3 80/F UTI 9/7.5/3.61 0.25/8 18.24 3.93 10.05 7.99 1.00
4 67/F MRSA
bacteraemia
8/7.5/4.05 0.30/6 32.62 9.52 11.08 7.21 1.11
5 80/F UTI, old stroke 4/7.5/5.36 0.40/6 21.18 6.06 22.29 17.93 0.91
6b 88/F UTI, CHF 4/7.5/5.99 0.40/6 30.51 12.54 21.26 16.73 0.92
7 54/F Pneumonia, old
stroke
18/7.0a/1.97a 0.30/6 23.04 5.13 17.25 13.69 1.03
8 67/M Pneumonia 4/7.5/3.93 0.40/6 16.74 3.00 12.46 9.31 0.92
9 79/F Pneumonia, CHF 8/7.5/6.07 0.30/6 23.98 6.28 22.02 16.95 0.81




4/7.5/3.86 0.35/6 21.61 6.72 20.88 13.34 0.77
aTracheostomy tube and ΔPETT only an approximation as equation only available for an 8.0-mm tracheostomy.
bCheyne-Stokes breathing noted. cEvident abdominal muscle
contraction noted. FiO2 inspired oxygen fraction, ETT endotracheal tube, CHF congestive heart failure, COPD chronic obstructive pulmonary disease, Ers passive respiratory
system elastance, Ecw passive chest wall elastance, F female; M male, MV mechanical ventilation, MRSA methicillin-resistant Staphylococcus aureus, PEEP
positive end-expiratory pressure, Rmax passive maximum end-inspiratory resistance, Rmin passive minimum (airway) end-inspiratory resistance, UTI urinary tract infection,
ΔPoes/ΔPaw ratio of oesophageal pressure drop to airway pressure drop during airway occlusion, ΔPETT pressure loss through endotracheal or tracheostomy tube
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between Pmus, aw and Pmus, oes was from -11.2 to 8.8
cmH2O. The maximal muscular pressures estimated
from three different approaches under different PAV
gain levels are shown in Table 2. PAV60 was associated
with the highest probability (91%) of optimal Pmus ac-
cording to Pmus, aw (5–10 cmH2O). However, the best
PAV gain for optimal PAV assessed from Pmus, oes or
Pmus, oes, PEEPi was quite diverse and was absent in two
patients. The concordance rate for selection of optimal
PAV gain was <50% between Pmus, aw and Pmus, oes and
Pmus, aw and Pmus, oes, PEEPi.
Pmus,aw within 5–10 cmH2O was not present in PAV20
but was present in 11–82% of breaths in other PAV
gains. Around 80% of breaths in PAV50 or PAV60 were
associated with Pmus,aw within 5–10 cmH2O. PTPoes <224
cmH2O·s/min and PTPoes, PEEPi <255 cmH2O·s/min are
considered admissible according to Jubran et al. [13].
Despite the limited predictability of Pmus, oes or Pmus, oes,
PEEPi from Pmus, aw, patients with Pmus, aw between 5
and 10 cmH2O are had 93% probability of PTPoes <220
cmH2O·s/min and 88% probability of PTPoes, PEEPi <255
cmH2O·s/min, regardless of the PAV gain. Only two
breaths were associated with PTPoes values <40
cmH2O·s/min. When Pmus,aw was achieved within
5–10 cmH2O, three PAV gain levels (PAV40, PAV50
and PAV60) were associated with >90% probability of
admissible PTPoes and PTPoes, PEEPi.
Discussion
Our analyses revealed several interesting findings. First,
PTPoes and PTPoes, PEEPi significantly decreased with
increasing PAV gain in patients with PAV. Second, the
prediction of Pmus, oes or Pmus, oes, PEEPi from airway
pressure tracing had limited accuracy. Third, the deduc-
tion of PTPaw from ΔP may underestimate PTPoes or
PTPoes, PEEPi. Fourth, an optimal Pmus, aw (5–10 cmH2O)
could be achieved in 91% of patients with PAV60, and
despite the lack of accuracy for predicting Pmus, oes or
Pmus, oes, PEEPi from airway pressure tracing, maintaining
Pmus, aw within 5–10 cmH2O was associated with PTPoes
<224 cmH2O·s/min or PTPoes, PEEPi <255 cmH2O·s/min
in approximately 90% of breaths.
The significant increase in Paw, peak but minimal differ-
ence in tidal volume with increasing gain level indicates
substantial adaptation of muscular pressure during PAV
[18]. The lower elastance during low assist could be ex-
plained by high respiratory drive (i.e. inspiratory muscle
activity does not return to zero during the 300 ms occlu-
sion time), which underestimates the elastic recoil pres-
sure at end-inspiration. PEEPi is unlikely to be a cause
Fig. 2 Tidal volume, peak airway pressure (Paw, peak) and respiratory mechanics during proportional assist ventilation (PAV) under different gains. PAV20
indicates a mean gain level of 20%. Significant differences in tidal volume were found between PAV60 vs. PAV20, PAV70 vs. PAV20, PAV70 vs. PAV30,
and PAV70 vs. PAV40. Significant differences in Paw, peak were found among individual Paw, peak levels under different gains, except the Paw, peak of
PAV20 vs. Paw, peak of PAV30 and Paw, peak of PAV70 vs. Paw, peak of PAV80. For PAV-based patient elastance (Epav), significant differences were found
between PAV20 vs. PAV50, PAV60, PAV70, and PAV80; PAV30 vs. PAV50, PAV60, PAV70, and PAV80; PAV40 vs. PAV50, PAV60, PAV70, and PAV80; PAV50
vs. PAV70 and PAV80; PAV60 vs. PAV80; and PAV70 vs. PAV80. No significant difference was found in PAV-based patient resistance (Rpav) among various
gains. For the Epav and Rpav comparison, one patient was not included because of insufficient numbers of Epav and Rpav in PAV20 and PAV30
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because it did not increase with greater PAV assist in the
current study [9].
The algorithm proposed by Carteaux et al. [11] is a
simple bedside approach to estimate inspiratory muscu-
lar pressure (Pmus, aw) in mechanically ventilated patients
under PAV. We found it to be of limited value in
predicting Pmus, oes. Pmus, aw tends to overestimate Pmus, oes
in PAV20 but more commonly underestimates Pmus, oes
from PAV40 to PAV80. Therefore, the proportion of
alleviation of respiratory muscle output was usually
incompletely attained as the PAV gain intended it to be.
Besides, the wide 95% confidence interval from the
Bland-Altman analysis of Pmus, oes and Pmus, aw impli-
cated that Pmus, oes could not be accurately predicted by
Pmus, aw.
There are several possible explanations for these findings.
First, for the unique condition where Pmus, oes is usually
overestimated in PAV20, a reasonable cause could be the
ventilator flow control algorithm. Because respiratory effort
is maximal in PAV20, the proportional-integral-derivative
algorithm of the flow control system is prone to an airway
pressure overshoot by the end of inspiration, which is fur-
ther exaggerated fourfold in PAV20 for the calculation of
Pmus, aw [19, 20]. Second is a possible discrepancy between
PAV+ and CMV measured respiratory mechanics [10].
Although the PAV+ mode was continuously updated,
measured respiratory system resistance and elastance may
be different from those obtained under CMV [10]. More-
over, the respiratory system resistance measured by PAV+ is
not reliable in cases with severe expiratory flow limitations.
Third is the presence of PEEPi. In a recently published
PAV+ mode bench study [21], the assistance provided by
Fig. 3 Inspiratory pressure time product (PTP) under different gain levels.
PTP calculated from the difference between the oesophageal pressure
and the relaxed chest wall elastance curve (PTPoes) decreased
progressively with increasing gain with or without intrinsic positive end-
expiratory pressure (PEEPi). For PTPoes, a significant difference was found
between proportional assist ventilation 20% gain (PAV20) vs. PAV40,
PAV50, PAV60, PAV70, and PAV80; PAV30 vs. PAV50, PAV60, PAV70, and
PAV80; PAV40 vs. PAV60, PAV70, and PAV80; PAV50 vs. PAV70 and PAV80;
PAV60 vs. PAV80; and PAV70 vs. PAV80. Similar patterns were found with




Fig. 4 a Maximum muscular pressure (Pmus) determined using either
oesophageal pressure tracing or airway pressure under different
proportional assist ventilation (PAV) gains. Significant differences (p<
0.05) were observed for all gain levels. b Bland-Altman analysis plot
showing bias and agreement between maximal muscular pressure
calculated from ΔP and PAV gain (Pmus, aw) and maximal muscular
pressure calculated from maximum difference between passive and
active Poes without consideration of PEEPi (Pmus, oes). The middle dashed
line is the mean difference (bias). The outer dashed line is the 95%
confidence interval of the difference between Pmus, aw and Pmus, oes
(±1.96 SD)
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Table 2 Maximal muscular pressures determined through airway or oesophageal pressure with and without PEEPi
Case Pmus and PEEPi (cmH2O) PAV20 PAV30 PAV40 PAV50 PAV60 PAV70 PAV80
1 Pmus, aw 25 18 15 11 9 7 4
Pmus, oes 20 19 18 13 15 13 7
Pmus, oes, PEEPi 21 22 19 14 16 14 8
PEEPi level 1.5 ± 0.8 2.6 ± 0.8 1.4 ± 0.5 0.7 ± 0.5 1.1 ± 0.7 1.4 ± 0.8 0.3 ± 0.3
2 Pmus, aw 19 13 10 8 6 5 3
Pmus, oes 16 15 16 13 13 14 11
Pmus, oes, PEEPi 17 17 17 14 15 15 12
PEEPi level 1.6 ± 0.7 1.1 ± 0.6 1.0 ± 0.6 1.4 ± 0.6 1.3 ± 0.8 1.3 ± 0.6 1.8 ± 0.6
3 Pmus, aw 17 10 8 6 5 4 3
Pmus, oes 17 14 13 14 11 11 8
Pmus, oes, PEEPi 18 16 14 15 12 14 9
PEEPi level 1.6 ± 0.9 1.9 ± 1.0 1.0 ± 0.8 0.7 ± 0.8 1.0 ± 0.8 1.4 ± 1.1 0.3 ± 0.6
4 Pmus, aw 17 13 10 8 6 5 3
Pmus, oes 14 16 11 11 10 8 5
Pmus, oes, PEEPi 15 17 13 12 11 9 6
PEEPi level 1.3 ± 0.9 1.2 ± 1.0 1.3 ± 0.9 1.7 ± 1.2 0.8 ± 0.4 1.2 ± 1.3 0.6 ± 0.5
5 Pmus, aw 13 9 7 5 5 4 3
Pmus, oes 9 9 8 7 8 6 4
Pmus, oes, PEEPi 10 10 9 8 8 6 4
PEEPi level 0.3 ± 0.2 0.4 ± 0.4 0.0 ± 0.1 0.1 ± 0.1 0.3 ± 0.4 0.0 ± 0.1 0.1 ± 0.1
6 Pmus, aw 23 18 13 11 9 7 6
Pmus, oes 21 21 17 20 17 14 13
Pmus, oes, PEEPi 27 28 19 27 23 18 18
PEEPi level 6.3 ± 4.0 7.4 ± 3.9 2.7 ± 1.4 6.8 ± 4.5 6.3 ± 4.8 4.2 ± 2.8 4.4 ± 3.2
7 Pmus, aw 14 9 7 5 4 3 2
Pmus, oes 4 5 4 4 3 2 2
Pmus, oes, PEEPi 7 7 7 6 4 4 3
PEEPi level 3.0 ± 0.9 2.9 ± 0.8 3.0 ± 1.5 2.1 ± 0.7 1.6 ± 0.8 1.5 ± 0.5 1.3 ± 0.8
8 Pmus, aw 20 14 10 8 6 5 3
Pmus, oes 14 13 10 10 8 7 7
Pmus, oes, PEEPi 16 15 12 10 9 8 8
PEEPi level 2.8 ± 0.7 2.2 ± 0.6 1.9 ± 0.8 0.8 ± 0.5 0.9 ± 0.3 1.0 ± 0.4 0.8 ± 0.4
9 Pmus, aw 26 18 13 9 8 5 3
Pmus, oes 12 11 10 8 8 6 4
Pmus, oes, PEEPi 14 13 12 10 10 8 6
PEEPi level 2.1 ± 0.7 2.0 ± 0.7 2.0 ± 0.7 1.8 ± 0.6 2.1 ± 0.5 1.6 ± 0.5 1.7 ± 0.4
10 Pmus, aw 26 14 9 8 6 5 4
Pmus, oes 16 15 15 13 11 11 9
Pmus, oes, PEEPi 17 16 16 14 12 12 11
PEEPi level 1.2 ± 1.0 1.2 ± 1.1 1.0 ± 1.0 0.4 ± 0.6 0.8 ± 0.8 0.1 ± 0.3 0.2 ± 0.5
11 Pmus, aw 28 19 14 12 10 7 4
Pmus, oes 16 14 13 12 8 12 5
Pmus, oes, PEEPi 28 32 29 28 17 18 10
PEEPi level 12.0 ± 1.3 17.9 ± 3.5 16.2 ± 1.7 15.9 ± 2.9 8.6 ± 1.7 6.0 ± 1.9 5.0 ± 1.4
Maximum muscular pressure and intrinsic positive end-expiratory pressure (PEEPi) were calculated as average of 1-minute breaths in each proportional assist
ventilation (PAV) gain. Muscular pressures between 5 and 10 cmH2O are highlighted. Pmus, aw maximal muscular pressure calculated from ΔP and PAV gain,
Pmus, oes maximal muscular pressure calculated from maximum difference between passive and active Poes without consideration of PEEPi, Pmus, oes, PEEPi maximal
muscular pressure calculated from maximum difference between passive and active Poes with consideration of PEEPi
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PAV+ was approximately 25% lower than expected. PEEPi
with the associated trigger delay was considered a major
factor affecting PAV+ accuracy due to the lack of assist
during the initial part of respiratory breath, ultimately
resulting in global under-assistance.
PTPoes is a better surrogate of respiratory effort in
ventilated patients. In this study, the analyses of correlation
between Pmus, aw and PTPaw, Pmus, oes and PTPoes, Pmus, oes,
PEEPi and PTPoes, PEEPi yielded highly significant results.
However, predicting PTP from Pmus, aw and Pmus, oes dif-
fered in the best-fit slope value. The slope value was 0.56
when the linear regression was performed between Pmus, aw
and PTPaw. The slope increased to 0.73 between PTPoes, br
and Pmus, oes and to 0.83 between PTPoes, PEEPi, br and Pmus,
oes, PEEPi. This implicates that the PTPaw should be
corrected when projecting into PTPoes. We offer the
following explanation for the discrepancy between PTPaw
and PTPoes. First, the assumption of a triangular pressure-
time product is flawed because respiratory muscle
pressure generation is usually exponential [22–24]. The
integration area above an exponential decay curve is usu-
ally larger than the integration area above a triangular line.
Second, the inspiratory time is significantly shortened in
high-gain PAV. The shortened inspiratory time should
result in a smaller PTPaw from the triangular algorithm. A
third possible cause is the influence of PEEPi. The
algorithm proposed by Cardeaux et al. is also flawed as it
does not consider PEEPi. The inclusion of PEEPi led to
increases in Pmus, oes, PEEPi and PTPoes, PEEPi.
The predefined range of respiratory effort by Carteaux
and colleagues [11] needs critical appraisal. Target limits of
Pmus, aw within 5–10 cmH2O or PTPaw between 50 and 150
cmH2O·s/min were derived mainly from a desirable inspira-
tory effort of PTPoes, PEEPi <125 cmH2O·s/min [14]. This
recommended threshold is arbitrary, not supported by
quantitative diaphragm electromyogram, and possibly well
below the threshold of threatening diaphragm fatigue [14].
A wider range of PTPoes, PEEPi should be allowable with
minimal risk of diaphragm fatigue [13, 25, 26]. As Pmus, aw
frequently underestimates Pmus, oes in the usual levels of
PAV, actual PTPoes, PEEPi values are usually higher than
PTPaw. Interestingly, PTPoes, PEEPi measurements were
usually <255 cmH2O·s/min when Pmus, aw were within
5–10 cmH2O. This implicates that the recommended grid
table for PAV remains a helpful reference for selecting the
PAV level, although the newly advocated threshold requires
further study for verification.
There are several limitations to the current study. The
first is the limited number of patients studied and the
fact that all of the patients had started to have weaning
trials as reflected by the oxygen fraction and external
PEEP level. Thus, our results may not be applicable to
acutely ill patients under mechanical ventilation. The
second is the lack of gastric pressure measurement,
which meant that we could not clarify the contribution
of expiratory muscle activity during PAV. However, we
did not notice evident abdominal muscle contraction
during PAV except in one patient with high PEEPi. Thus,
the measured Pmus, oes, PEEPi should represent the in-
spiratory muscle motor outputs for most of our patients.
Conclusions
In summary, our results demonstrate limited accuracy of
estimating respiratory effort from airway pressure tracing
during PAV. Although Pmus, oes decreases with increasing
PAV gain, Pmus, oes could not be precisely predicted from
ΔP under various gain factors. In addition, PTPaw also
underestimated PTPoes and PTPoes, PEEPi. However, when
the PAV gain was adjusted to a Pmus, aw of 5–10 cmH2O,
there was approximately 90% probability of maintaining the
patient within an acceptable PTP range.
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